Get the latest news on Zomedica stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ZOMDF performance

Latest Zomedica Stock News | OTC:ZOMDF | Benzinga

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Zomedica Corp

News

Press Releases

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth

Comments

Zomedica Stock News

News

Latest Zomedica Stock News | OTC:ZOMDF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga